APSARD News & Updates
APSARD News & Updates contains content that addresses mental health practitioners, children and adults, ADHD and related disorders, and overall membership updates.
All APSARD members can submit their news and updates for posting. Submit your content to info@apsard.org for review and approval. Click the link below to reference a guide on how to write an article.
Please view and read the disclaimer before using News & Updates, by using News & Updates you agree to the terms and conditions.
➜ How to write an article
➜ Disclaimer
Featured Post
Stay in the Know with the latest APSARD News
Latest Posts
Genomics in ADHD: what’s new and what’s next?
Genomics in ADHD: what’s new and what’s next? Philip Shaw, BM BCh (Medicine), PhD Researcher and Psychiatrist. Background Most clinicians are aware that ADHD “runs in families.” When assessing a child or young person, one of the questions we ask is if anyone in...
APSARD Newsletter – June 2024
The APSARD June 2024 Newsletter is now available! Click the button below to access.
APSARD Newsletter – May 2024
The APSARD May 2024 Newsletter is now available! Click the button below to access.
APSARD Newsletter – April 2024
The APSARD April 2024 Newsletter is now available! Click the button below to access.
Important Update: Department of Justice, CDC, and the Vital Role of APSARD
On June 13th, 2024, the US Department of Justice announced a federal health care fraud indictment against a large subscription-based telehealth company that provides attention-deficit/hyperactivity disorder (ADHD) treatment to approximately 30,000-50,000 patients...
CDC Releases New ADHD Prevalence Paper
Key Findings: New data show that ADHD among U.S. children continues to be a substantial public health concern based on 2022 data (National Survey of Children’s Health). The estimated number of children aged 3–17 years with diagnosed ADHD increased from 2016 to 2022...
NYT on Why Primary Care is in Need of Adult ADHD Guidelines
In this issue of Psychiatric Annals, we will present four articles summarizing issues in the development of United States (US) guidelines for the diagnosis and treatment of adults with attention-deficit/hyperactivity disorder (ADHD). The American Professional Society...
Expert Consensus Statement, including APSARD President, for Telepsychiatry and ADHD
Read the full statement:...
APSARD 2024: A Huge Success
The members are the judges! From the feedback we've heard, APSARD 2024 went very well with a strong line-up of presenters sharing interesting and important science. From attendees: Excellent conference, both in content and the quality Great speakers; great...